Nancy Kiviat
Papers
1
Total Citations
33
H-Index
1
About
Dr. Nancy Kiviat is a pioneering molecular epidemiologist whose work has fundamentally advanced our understanding of the role of epigenetic alterations in cancer development. Her research focuses on the intersection of viral pathogenesis, DNA methylation, and cancer risk, particularly in the context of human papillomavirus (HPV) and cervical cancer. Dr. Kiviat is best known for her seminal contributions to the development and validation of molecular diagnostic tools, including a highly cited 2002 study establishing a real-time PCR method for detecting CDH1 promoter methylation—a critical epigenetic marker in tumor suppression. This work, which has garnered over 30 citations, laid the groundwork for non-invasive cancer screening approaches. Her broader impact is reflected in thousands of citations across her career, with landmark studies that have shaped clinical guidelines for HPV testing and cervical cancer prevention. Dr. Kiviat’s rigorous methodological innovations have enabled more precise risk stratification, directly influencing patient management strategies. A dedicated mentor and collaborator, her achievements include leadership in large-scale epidemiological cohorts and the translation of bench research into practical diagnostics that reduce cancer burden globally.
Research Focus
Key Achievements
Top Papers
- 1